Xvivo Perfusion AB
STO:XVIVO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
256.5
539
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Xvivo Perfusion AB
Relative Value
The Relative Value of one
XVIVO
stock under the Base Case scenario is
193.52
SEK.
Compared to the current market price of 451.5 SEK,
Xvivo Perfusion AB
is
Overvalued by 57%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
XVIVO Competitors Multiples
Xvivo Perfusion AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Xvivo Perfusion AB
STO:XVIVO
|
14.2B SEK | 18.9 | 69.6 | 242.9 | 242.9 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.8T JPY | 8.5 | 35.6 | 23.5 | 28.5 | |
| CH |
|
Alcon AG
SIX:ALC
|
37.9B CHF | 4.3 | 36.5 | 17.9 | 34.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
200.9B DKK | 7.4 | 39.8 | 25.4 | 29.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
16.9B USD | 4.3 | 38.2 | 19.3 | 23.3 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
9.9T KRW | 190 | -53.1 | -81.8 | -77.1 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.9B USD | 1.5 | -18.7 | 17.5 | 58.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
48.6B CNY | 11.4 | 26.9 | 23.1 | 23.1 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
6.3B USD | 4.2 | 14.7 | 10.1 | 11.4 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
6.1B USD | 4.6 | 51.1 | 25.4 | 41.7 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.8B GBP | 2.8 | 39.5 | 265.2 | 463.3 |
You don't have any saved screeners yet
